Wilson Disease Association

Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate

By Wilson Disease|2024-10-25T12:12:18+00:00October 25, 2024|News and Notices|

Ultragenyx letter to the WD community

By Wilson Disease|2024-10-25T12:11:41+00:00October 25, 2024|News and Notices|

Gene therapy updates from the WDA

By Wilson Disease|2024-10-25T12:10:21+00:00October 25, 2024|News and Notices|

WDA designates newest Wilson Disease Center of Excellence at University of California, Davis

By Wilson Disease|2024-09-09T12:30:13+00:00September 9, 2024|News and Notices|

Vivet Therapeutics Wilson Disease Update April 2024

By Wilson Disease|2024-04-16T18:50:47+00:00April 16, 2024|Clinical Trials, News and Notices|

Ultragenyx Wilson Disease Update April 2024

By Wilson Disease|2024-04-16T18:46:11+00:00April 4, 2024|Clinical Trials, News and Notices|

One Step Closer to a Newborn Screening Test for Wilson Disease

By Wilson Disease|2024-04-16T18:53:20+00:00March 29, 2024|News and Notices|

Ultragenyx Wilson Disease Gene Therapy Trial Update for WDA

By Wilson Disease|2024-04-16T18:47:31+00:00November 13, 2023|Clinical Trials|

Rare Affair

By Wilson Disease|2023-11-07T20:57:29+00:00October 18, 2023|Tickets|

Vivet Therapeutics’ Wilson Disease Gene Therapy Clinical Trial Update

By Wilson Disease|2023-09-20T17:25:53+00:00September 20, 2023|Clinical Trials|